Search filters

List of works by Dayson Moreira

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

Automated in vivo Assessment of Vascular Response to Radiation using a Hybrid Theranostic X-ray Irradiator/Fluorescence Molecular Imaging System

scientific article published on 15 May 2020

B Cell Lymphoma Immunotherapy Using TLR9-Targeted Oligonucleotide STAT3 Inhibitors

scientific article published on 17 January 2018

Bortezomib (PS-341) treatment decreases inflammation and partially rescues the expression of the dystrophin-glycoprotein complex in GRMD dogs

scientific article

Cell death-associated molecular-pattern molecules: inflammatory signaling and control

scientific article

Cell-selective oligonucleotide STAT3 inhibitor for immunotherapy of human acute myeloid leukemia.

scientific article published on 4 November 2015

Dermcidin exerts its oncogenic effects in breast cancer via modulation of ERBB signaling.

scientific article

Identification of a metallopeptidase with TOP-like activity in Paracoccidioides brasiliensis, with increased expression in a virulent strain

scientific article published on 05 July 2011

Intracellular processing of immunostimulatory CpG-siRNA: Toll-like receptor 9 facilitates siRNA dicing and endosomal escape

scientific article published on 15 June 2013

Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity.

scientific article published on 29 October 2013

Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity

scientific article published on 24 November 2020

Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo

scientific article published on 01 January 2020

Myeloid cells as a target for oligonucleotide therapeutics: turning obstacles into opportunities

scientific article published on 18 February 2017

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

scientific article published on 13 April 2019

STAT3 Inhibition Combined with CpG Immunostimulation Activates Antitumor Immunity to Eradicate Genetically Distinct Castration-Resistant Prostate Cancers

scientific article published on 18 October 2018

Serum-resistant CpG-STAT3 decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia

scientific article published on 21 January 2016

TLR9 expression and secretion of LIF by prostate cancer cells stimulates accumulation and activity of polymorphonuclear MDSCs

scientific article published on 22 May 2017

TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells

scientific article

TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients

scientific article

TLR9-Targeted SiRNA Delivery In Vivo

scientific article published on January 2016

Targeted TLR9-activation/STAT3-blocking abrogates immunosuppressive functions of myeloid-derived suppressor cells from late-stage prostate cancer patients

Targeted in vivo delivery of NF-κB decoy inhibitor augments sensitivity of B-cell lymphoma to therapy

scientific article published on 25 November 2020

Using Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer Therapy

scientific article

Paulina is supported by:

About Paulina

Help